Drugs to Watch 2020
Market intelligence reports
BioWorld - Tuesday, February 25, 2020
» Regulatory submissions, approvals and other actions: January 2020
Looking to read the full article? Subscribe to BioWorld.
Regulatory submissions, approvals and other actions: January 2020
February 14, 2020
Regulatory decisions affecting biopharma products in development, including: Abbvie, Aimmune, Alkermes, Alnylam, Amarin, Biohaven, Biolinerx, Blueberry, Clovis, Cytodyn, Durect, Emergent, Evoke, Exelixis, Fate, F-star, Galapagos, Genmab, Horizon, Incyte, Ipsen, Janssen, Jubilant, Mesoblast, Nabriva, Nektar, Nicox, Orion, Pharmacyte, Pharming, Pulmatrix, Recordati, Regeneron, Seelos, Sorrento, Ultragenyx, Vistagen.
Analysis and data insight
Already a subscriber?